| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1839* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 484* | 2021 |
| Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions L Bottaci, PJ Drew, JE Hartley, MB Hadfield, R Farouk, PWR Lee, ... The Lancet 350 (9076), 469-472, 1997 | 281 | 1997 |
| Long‐term adverse effects of paracetamol–a review JC McCrae, EE Morrison, IM MacIntyre, JW Dear, DJ Webb British journal of clinical pharmacology 84 (10), 2218-2230, 2018 | 257 | 2018 |
| Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies B Williams, TM MacDonald, SV Morant, DJ Webb, P Sever, GT McInnes, ... The lancet Diabetes & endocrinology 6 (6), 464-475, 2018 | 226 | 2018 |
| Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease N Dhaun, IM MacIntyre, D Kerr, V Melville, NR Johnston, S Haughie, ... Hypertension 57 (4), 772-779, 2011 | 157 | 2011 |
| Blood pressure–independent reduction in proteinuria and arterial stiffness after acute endothelin-A receptor antagonism in chronic kidney disease N Dhaun, IM MacIntyre, V Melville, P Lilitkarntakul, NR Johnston, ... Hypertension 54 (1), 113-119, 2009 | 136 | 2009 |
| Chorioretinal thinning in chronic kidney disease links to inflammation and endothelial dysfunction C Balmforth, JJMH van Bragt, T Ruijs, JR Cameron, R Kimmitt, ... JCI insight 1 (20), 2016 | 93 | 2016 |
| Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis N Dhaun, P Lilitkarntakul, IM MacIntyre, E Muilwijk, NR Johnston, ... American Journal of Physiology-Renal Physiology 296 (6), F1477-F1483, 2009 | 92 | 2009 |
| Diurnal variation in blood pressure and arterial stiffness in chronic kidney disease: the role of endothelin-1 N Dhaun, R Moorhouse, IM MacIntyre, V Melville, W Oosthuyzen, ... Hypertension 64 (2), 296-304, 2014 | 71 | 2014 |
| Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney N Dhaun, IM MacIntyre, COC Bellamy, DC Kluth American journal of kidney diseases 54 (4), 726-731, 2009 | 53 | 2009 |
| Regular acetaminophen use and blood pressure in people with hypertension: the PATH-BP trial IM MacIntyre, EJ Turtle, TE Farrah, C Graham, JW Dear, DJ Webb Circulation 145 (6), 416-423, 2022 | 43 | 2022 |
| Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney disease N Dhaun, IM MacIntyre, V Melville, P Lilitkarntakul, NR Johnston, ... Hypertension 54 (3), e19-e20, 2009 | 35 | 2009 |
| PATH-BP (Paracetamol in Hypertension–Blood Pressure) Investigators*. Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial IM MacIntyre, EJ Turtle, TE Farrah, C Graham, JW Dear, DJ Webb Circulation 145 (6), 416-423, 2022 | 19 | 2022 |
| Plasma pro‐endothelin‐1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism N Dhaun, J Yuzugulen, RA Kimmitt, EG Wood, P Chariyavilaskul, ... Journal of the American Heart Association 4 (3), e001624, 2015 | 18 | 2015 |
| Greater Functional ETB Receptor Antagonism With Bosentan Than Sitaxsentan in Healthy Men IM MacIntyre, N Dhaun, P Lilitkarntakul, V Melville, J Goddard, DJ Webb Hypertension 55 (6), 1406-1411, 2010 | 18 | 2010 |
| Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure IM MacIntrye, PS Jhund, JJV McMurray Cardiovascular drugs and therapy 19, 261-265, 2005 | 17 | 2005 |
| A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage … MK Hayer, NC Edwards, G Slinn, WE Moody, RP Steeds, CJ Ferro, ... American Heart Journal 191, 37-46, 2017 | 16 | 2017 |
| Prolonged SARS‐CoV‐2 viral shedding in patients with chronic kidney disease ED O'Sullivan, JS Lees, KL Howie, D Pugh, KA Gillis, JP Traynor, ... Nephrology 26 (4), 328-332, 2021 | 15 | 2021 |
| First-in-man demonstration of direct endothelin-mediated natriuresis and diuresis RW Hunter, R Moorhouse, TE Farrah, IM MacIntyre, T Asai, PJ Gallacher, ... Hypertension 70 (1), 192-200, 2017 | 14 | 2017 |
Ewan D. KennedyThe University of Edinburgh, The University of GlasgowVerified email at doctors.org.uk
